CD20单抗，上市。
TGTX Announces Commercial Launch of BRIUMVI for the Treatment of Adult Patients with Relapsing Forms of MS .$TG治疗(TGTX)$
| 发布于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
CD20单抗，上市。
TGTX Announces Commercial Launch of BRIUMVI for the Treatment of Adult Patients with Relapsing Forms of MS .$TG治疗(TGTX)$